Download - Global Skin Care
-
8/18/2019 Global Skin Care
1/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 1
MarketLine Industry Profile
Global Skincare August 2015Reference Code: 0199-0708
Publication Date: August 2015
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
A Progressive Digital Media business
http://www.marketlineinfo.com/http://www.marketlineinfo.com/http://www.marketlineinfo.com/
-
8/18/2019 Global Skin Care
2/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 2
EXECUTIVE SUMMARY
Market valueThe global skincare market grew by 5.8% in 2014 to reach a value of $83,424.7 million.
Market value forecastIn 2019, the global skincare market is forecast to have a value of $113,284.4 million, an increase of 35.8% since 2014.
Market volumeThe global skincare market grew by 4.5% in 2014 to reach a volume of 11,886.4 million units.
Market volume forecastIn 2019, the global skincare market is forecast to have a volume of 15,268.1 million units, an increase of 28.4% since
2014.
Category segmentationFacial care is the largest segment of the global skincare market, accounting for 66.1% of the market's total value.
Geography segmentation Asia-Pacific accounts for 44.4% of the global skincare market value.
Market shareL'Oreal S.A. is the leading player in the global skincare market, generating a 13.2% share of the market's value.
Market rivalryRivalry is assessed as moderate, as market players tend to be large, but also fairly diversified, and in recent years
growth has worked to alleviate pressure somewhat.
-
8/18/2019 Global Skin Care
3/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 3
TABLE OF CONTENTS
Executive Summary ................................................................................... ............................................................... ..... 2
Market value ........................................................... ................................................................. ................................... 2
Market value forecast ........................................................ ................................................................. ........................ 2
Market volume ........................................................ ................................................................. ................................... 2
Market volume forecast ..................................................... ................................................................. ........................ 2
Category segmentation .......................................................................... ............................................................... ..... 2
Geography segmentation ............................................................................................. .............................................. 2
Market share ................................................................................ .............................................................. ................ 2
Market rivalry .......................................................... ................................................................. ................................... 2
Market Overview .............................................................................. .............................................................. ................ 7
Market definition ........................................................................................................... .............................................. 7
Market analysis ....................................................................................... .............................................................. ..... 7
Market Data .................................................... ................................................................. .............................................. 8
Market value ........................................................... ................................................................. ................................... 8
Market volume ........................................................ ................................................................. ................................... 9
Market Segmentation ....................................................................................................... ............................................ 10
Category segmentation ................................................................................................ ............................................ 10
Geography segmentation ............................................................................................. ............................................ 11
Market share ..................................................................................................... ....................................................... 12
Market distribution ........................................................................................................ ............................................ 13
Market Outlook ........................................................... ................................................................. ................................. 14
Market value forecast ........................................................ ................................................................. ...................... 14
Market volume forecast ..................................................... ................................................................. ...................... 15
Five Forces Analysis .................................................................................. ............................................................... ... 16
Summary ..................................................... ................................................................. ............................................ 16
Buyer power ...................................................................................................... ....................................................... 17
Supplier power .................................................................................................. ....................................................... 18
New entrants ................................................................................................................ ............................................ 19
Threat of substitutes .......................................................... ................................................................. ...................... 21
Degree of rivalry ..................................................... ................................................................. ................................. 22
Leading Companies ........................................................................ ............................................................... .............. 23
-
8/18/2019 Global Skin Care
4/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 4
Beiersdorf AG ......................................................... ................................................................. ................................. 23
Johnson & Johnson ........................................................... ................................................................. ...................... 26
L'Oreal S.A. ............................................................ ................................................................. ................................. 30
Unilever ....................................................... ................................................................. ............................................ 33
Methodology................................................................................................................................................................. 36
Industry associations ......................................................... ................................................................. ...................... 37
Related MarketLine research ....................................................... .............................................................. .............. 37
Appendix ......................................................... ................................................................. ............................................ 38
About MarketLine .............................................................. ................................................................. ...................... 38
-
8/18/2019 Global Skin Care
5/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 5
LIST OF TABLES
Table 1: Global skincare market value: $ million, 2010 –14 ............................................................................ ................ 8
Table 2: Global skincare market volume: million units, 2010 –14.................................................................... ................ 9
Table 3: Global skincare market category segmentation: $ mill ion, 2014 ................................ .................................... 10
Table 4: Global skincare market geography segmentation: $ million, 2014 ................................................................. 11
Table 5: Global skincare market share: % share, by value, 2014 .................................... ............................................ 12
Table 6: Global skincare market distribution: % share, by value, 2014 ........................................................................ 13
Table 7: Global skincare market value forecast: $ million, 2014 –19 ........................................... ................................. 14
Table 8: Global skincare market volume forecast: million units, 2014 –19 .................................................................... 15
Table 9: Beiersdorf AG: key facts............................... ................................................................. ................................. 23
Table 10: Beiersdorf AG: key financials ($) ........................................................... ....................................................... 24
Table 11: Beiersdorf AG: key financials (€) ............................................................................................................... ... 24
Table 12: Beiersdorf AG: key financial ratios ........................................................ ....................................................... 24
Table 13: Johnson & Johnson: key facts ............................................................... ....................................................... 26
Table 14: Johnson & Johnson: key financials ($) ...................................................................................................... ... 27
Table 15: Johnson & Johnson: key financial ratios ............... .............................................................. ......................... 28
Table 16: L'Oreal S.A.: key facts .................................................................................................................... .............. 30
Table 17: L'Oreal S.A.: key financials ($) .................................................................................... ................................. 31
Table 18: L'Oreal S.A.: key financials (€) .................................................................................... ................................. 31
Table 19: L'Oreal S.A.: key financial ratios ............................................................ ....................................................... 31
Table 20: Unilever: key facts .................................................................................................... .................................... 33
Table 21: Unilever: key financials ($) .......................................................................................... ................................. 34
Table 22: Unilever: key financials (€) ............................................................................... ............................................ 34
Table 23: Unilever: key financial ratios........................................................ .............................................................. ... 34
-
8/18/2019 Global Skin Care
6/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 6
LIST OF FIGURES
Figure 1: Global skincare market value: $ million, 2010 –14 ........................................................................................... 8
Figure 2: Global skincare market volume: million units, 2010 –14 .................................... .............................................. 9
Figure 3: Global skincare market category segmentation: % share, by value, 2014 .................................................... 10
Figure 4: Global skincare market geography segmentation: % share, by value, 2014 ................................................. 11
Figure 5: Global skincare market share: % share, by value, 2014 ............................................................................... 12
Figure 6: Global skincare market distribution: % share, by value, 2014 ......................................................... .............. 13
Figure 7: Global skincare market value forecast: $ million, 2014 –19 ................................................................ ........... 14
Figure 8: Global skincare market volume forecast: million units, 2014 –19 ................................................................... 15
Figure 9: Forces driving competition in the global skincare market, 2014 ...................................................... .............. 16
Figure 10: Drivers of buyer power in the global skincare market, 2014 .......................................................... .............. 17
Figure 11: Drivers of supplier power in the global skincare market, 2014 .................................................................... 18
Figure 12: Factors influencing the likelihood of new entrants in the global skincare market, 2014 .............................. 19
Figure 13: Factors influencing the threat of substitutes in the global skincare market, 2014 ....................................... 21
Figure 14: Drivers of degree of rivalry in the global skincare market, 2014 ............................................................... ... 22
Figure 15: Beiersdorf AG: revenues & profitability ................................................................... .................................... 25
Figure 16: Beiersdorf AG: assets & liabilities ........................................................ ....................................................... 25
Figure 17: Johnson & Johnson: revenues & profitability .................. .............................................................. .............. 28
Figure 18: Johnson & Johnson: assets & liabilities ............... .............................................................. ......................... 29
Figure 19: L'Oreal S.A.: revenues & profitability ............................................................... ............................................ 32
Figure 20: L'Oreal S.A.: assets & liabilities ............................................................ ....................................................... 32
Figure 21: Unilever: revenues & profitability .......................................................... ....................................................... 35
Figure 22: Unilever: assets & l iabilities ........................................................ .............................................................. ... 35
-
8/18/2019 Global Skin Care
7/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 7
MARKET OVERVIEW
Market definitionThe skincare market consists of the retail sale of facial care, body care, suncare, hand care, depilatories, and make-up
remover products.
The market is valued according to retail selling price (RSP) and includes any applicable taxes.
Any currency conversions used in the creation of this report have been calculated using constant 2014 annual average
exchange rates.
For the purposes of this report, Europe consists of Western Europe and Eastern Europe.
Western Europe comprises Austria, Belgium, Denmark, France, Finland, Germany, Greece, Italy, Ireland, the
Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Eastern Europe comprises the Czech Republic, Hungary, Poland, Romania, Russia, and Turkey.
For the purposes of this report, North America consists of Canada, Mexico, and the United States.
South America comprises Argentina, Brazil, Colombia, and Venezuela.
Europe comprises Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy,
Netherlands, Norway, Poland, Portugal, Romania, Russia, Spain, Sweden, Switzerland, Turkey, and the United
Kingdom.
Scandinavia comprises Denmark, Finland, Norway, and Sweden.
Asia-Pacific comprises Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines,
Singapore, South Korea, Taiwan, Thailand, and Vietnam.
Middle East comprises Saudi Arabia and United Arab Emirates.
Market analysisThe global skincare market saw moderate to strong rate of value growth over the period 2010-2014. Growth is projected
to continue over the forecast period however, at an accelerating rate, with annual growth rates largely remaining above
6%.
A myriad of factors have contributed to growth in this market. In developing countries, increasing middle class sizes and
disposable income have driven demand for skincare products, particularly in China and India.
The global skincare market had total revenues of $83,424.7m in 2014, representing a compound annual growth rate
(CAGR) of 4.6% between 2010 and 2014. In comparison, the European and Asia-Pacific markets grew with CAGRs of
3% and 6% respectively, over the same period, to reach respective values of $27,978.4m and $37,015.4m in 2014.
Market consumption volume increased with a CAGR of 4.4% between 2010 and 2014, to reach a total of 11.9 billion
units in 2014. The market's volume is expected to rise to 15.3 billion units by the end of 2019, representing a CAGR of
5.1% for the 2014-2019 period.
The facial care segment was the market's most lucrative in 2014, with total revenues of $55,142.2m, equivalent to 66.1%
of the market's overall value. The body care segment contributed revenues of $11,959.4m in 2014, equating to 14.3% of
the market's aggregate value.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 6.3% for the five-year period 2014
- 2019, which is expected to drive the market to a value of $113,284.4m by the end of 2019. Comparatively, the
European and Asia-Pacific markets will grow with CAGRs of 4.2% and 7.4% respectively, over the same period, to reach
respective values of $34,364.4m and $53,006.3m in 2019.
-
8/18/2019 Global Skin Care
8/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 8
MARKET DATA
Market valueThe global skincare market grew by 5.8% in 2014 to reach a value of $83,424.7 million.
The compound annual growth rate of the market in the period 2010 –14 was 4.6%.
Table 1: Global skincare market value: $ million, 2010 –14
Year $ million € million % Growth
2010 69,591.9 52,364.1
2011 72,521.7 54,568.7 4.2%
2012 75,610.8 56,893.0 4.3%
2013 78,850.3 59,330.6 4.3%
2014 83,424.7 62,772.6 5.8%
CAGR: 2010 –14 4.6%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 1: Global skincare market value: $ million, 2010 –14
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
9/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 9
Market volumeThe global skincare market grew by 4.5% in 2014 to reach a volume of 11,886.4 million units.
The compound annual growth rate of the market in the period 2010 –14 was 4.4%.
Table 2: Global skincare market volume: million units, 2010 –14
Year million units % Growth
2010 10,020.3
2011 10,448.9 4.3%
2012 10,896.8 4.3%
2013 11,374.3 4.4%
2014 11,886.4 4.5%
CAGR: 2010 –14 4.4%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 2: Global skincare market volume: million units, 2010 –14
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
10/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 10
MARKET SEGMENTATION
Category segmentationFacial care is the largest segment of the global skincare market, accounting for 66.1% of the market's total value.
The Body care segment accounts for a further 14.3% of the market.
Table 3: Global skincare market category segmentation: $ million, 2014
Category 2014 %
Facial care 55,142.2 66.1%
Body care 11,959.4 14.3%
Suncare 8,537.5 10.2%
Hand care 4,428.5 5.3%
Make-up remover 1,680.5 2.0%Depilatories 1,676.6 2.0%
Total 83,424.7 99.9%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 3: Global skincare market category segmentation: % share, by value, 2014
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
11/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 11
Geography segmentation Asia-Pacific accounts for 44.4% of the global skincare market value.
Europe accounts for a further 33.5% of the global market.
Table 4: Global skincare market geography segmentation: $ million, 2014
Geography 2014 %
Asia-Pacific 37,015.4 44.4
Europe 27,978.4 33.5
Americas 17,497.7 21.0
Middle East & Africa 933.3 1.1
Total 83,424.8 100%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 4: Global skincare market geography segmentation: % share, by value, 2014
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
12/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 12
Market shareL'Oreal S.A. is the leading player in the global skincare market, generating a 13.2% share of the market's value.
Unilever accounts for a further 9.8% of the market.
Table 5: Global skincare market share: % share, by value, 2014
Company % Share
L'Oreal S.A. 13.2%
Unilever 9.8%
Beiersdorf AG 8.8%
Johnson & Johnson 6.6%
Other 61.6%
Total 100%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 5: Global skincare market share: % share, by value, 2014
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
13/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 13
Market distributionSupermarkets / hypermarkets form the leading distribution channel in the global skincare market, accounting for a 34.6%
share of the total market's value.
Specialist retailers accounts for a further 28.7% of the market.
Table 6: Global skincare market distribution: % share, by value, 2014
Channel % Share
Supermarkets / hypermarkets 34.6%
Specialist retailers 28.7%
Pharmacies / drugstores 12.1%
Department stores (incl. duty-free shops) 9.9%
Other 14.7%
Total 100%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 6: Global skincare market distribution: % share, by value, 2014
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
14/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 14
MARKET OUTLOOK
Market value forecastIn 2019, the global skincare market is forecast to have a value of $113,284.4 million, an increase of 35.8% since 2014.
The compound annual growth rate of the market in the period 2014 –19 is predicted to be 6.3%.
Table 7: Global skincare market value forecast: $ million, 2014 –19
Year $ million € million % Growth
2014 83,424.7 62,772.6 5.8%
2015 88,310.9 66,449.1 5.9%
2016 94,005.9 70,734.3 6.4%
2017 99,897.7 75,167.6 6.3%
2018 106,301.3 79,985.9 6.4%2019 113,284.4 85,240.4 6.6%
CAGR: 2014 –19 .3%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 7: Global skincare market value forecast: $ million, 2014 –19
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
15/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 15
Market volume forecastIn 2019, the global skincare market is forecast to have a volume of 15,268.1 million units, an increase of 28.4% since
2014.
The compound annual growth rate of the market in the period 2014 –19 is predicted to be 5.1%.
Table 8: Global skincare market volume forecast: million units, 2014 –19
Year million units % Growth
2014 11,886.4 4.5%
2015 12,438.5 4.6%
2016 13,063.3 5.0%
2017 13,739.2 5.2%
2018 14,474.0 5.3%
2019 15,268.1 5.5%
CAGR: 2014 –19 5.1%
SOURCE: MARKETLINE M A R K E T L I N E
Figure 8: Global skincare market volume forecast: million units, 2014 –19
SOURCE: MARKETLINE M A R K E T L I N E
-
8/18/2019 Global Skin Care
16/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 16
FIVE FORCES ANALYSIS
The skincare market will be analyzed taking manufacturers of body care, depilatories, facial care, hand care, make-up
remover and sun care products, as well as packaging providers as players. The key buyers will be taken as retailers, and
manufacturers of fine chemicals, vegetable oils, and other ingredients needed for cosmetic production as the key
suppliers.
SummaryFigure 9: Forces driving competition in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
Rivalry is assessed as moderate, as market players tend to be large, but also fairly diversified, and in recent years
growth has worked to alleviate pressure somewhat.
Buyer power in this market is assessed as moderate, as although manufacturers can exert pressure on retailers through
marketing campaigns and the development of novel products, many retailers are very diversified, and sometimes
backward integrated.
Likewise, supplier power is also assessed as moderate, as although there are no substitutes for some raw materials in
this market, these are the exceptions rather than the norm, and market players can usually find alternatives when
required. The quality of the raw materials is highly important. Health scares and the possible dangers of syntheticchemicals used in beauty and personal care raise consumers demand for safer and healthier alternatives and increase
their interest in product quality and safety issues.
The threat of new entrants is also seen as moderate, since although brand power is important, the market is fairly heavily
regulated, and operating and exit costs are high.
The potential for substitution in this market is weak; there are few substitutes available other than homemade or 'artisan'
products, most of which cannot offer the same range of benefits and special features as market players' output and may
be either unpredictable in results or carry greater risk and expense (in the case of cosmetic surgery). In 2014 plastic
surgery and advanced cosmetology is becoming an increasingly common practice. Among the most popular treatments
are facelifts, Botox injections or collagen rebuilding.
-
8/18/2019 Global Skin Care
17/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 17
Buyer powerFigure 10: Drivers of buyer power in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
The main market players invest significant sums in to research and the development of new products, especially those
aimed at consumers in developing economies. These R&D efforts serve to increase differentiation between market
players, weakening buyer power.
Moreover, by heavily marketing these new products, manufacturers drive up demand and bolster brand loyalty, thereby
pressuring retailers in to stocking certain ranges. This further weakens buyer power in this industry.
Some players have also integrated forward with retail operations of their own, (for example, L'Oreal's acquisition of Body
Shop). This also weakens buyer power, although this approach is not an especially common strategy.
On the other hand, major retailers in the skincare market wield considerable bulk-purchasing power, and also often offer
a range of private-label brands. Both of these factors increase buyer power considerably.
Buyer power is further strengthened by the fact that for many players, skincare products are only a minor revenue
stream. This is especially true of large retailers such as supermarkets, who offer a very diverse range of products.
Overall, buyer power is assessed as moderate.
-
8/18/2019 Global Skin Care
18/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 18
Supplier powerFigure 11: Drivers of supplier power in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
Suppliers in the skincare market include the manufacturers of fine chemicals, vegetable oils and other ingredients used
in the production of cosmetics. Plastic, glass and metal packaging is an additional input here.
The quality of raw materials is often highly important in this market. The potential dangers associated with the use of
synthetic chemicals in the beauty industry have increased consumer demand for safer and healthier alternatives, and
driven up interest in product quality and safety issues. This also serves to weaken supplier power somewhat. Chemicals
used in supplies must be of a standard suitable for manufacturing consumer products.
For some chemicals there are no substitutes, which increases supplier power, but this is the exception rather than the
norm: there are generally several alternative products within each ingredient category, reducing players' dependence on
any particular supplier.
Overall, supplier power is assessed as moderate.
-
8/18/2019 Global Skin Care
19/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 19
New entrantsFigure 12: Factors influencing the likelihood of new entrants in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
The main manufacturers in this market are large, international companies, which invest heavily in both product
innovation and the building of brand portfolios. Thus, new entrants face formidable competition.
New entrants must also persuade stores to stock their products. Major retailers are aware of their importance in the
distribution chain and may be unwilling to take the risk of displacing existing well-established brands for new ones.
Supermarkets and hypermarkets distribute the largest share of skincare products globally, accounting for 34.6% of the
total sales. Specialist retailers account for a further 28.7% of the global distribution channels.
Entering the skincare market also requires a new player to establish production facilities, demanding significant capital
outlay on machinery and factories. Skincare products are generally sold in high volume to a large number of consumers,
and the reasonably high level of consolidation seen in most skincare markets suggests that scale economies in
manufacturing are likely to be important to the margins of players, acting as another entry barrier for potential new
entrants.
Newcomers may be able to start on a small scale, such as niche companies like Lush, which entered the UK market as a
start-up in 1978, selling only handmade products. While small in comparison to the market leaders, Lush has grown to
operate 370 stores worldwide. Focusing on a niche market such as The growing market for male skincare especially in
Asia, is one example of a potential entry point.
Entry barriers include government legislation, which often enforces strict regulations on the composition and testing of
skin care products. In Asia-Pacific in particular this can also present a number of obstacles due to different regulatory
requirements in each country; i.e. certain cosmetics are classified as cosmetics in some countries, while in others the
same products as regulated as over the counter drugs or quasi-drugs.
Moreover, consumers are paying closer attention to what comes directly in contact with their skin to prevent skin
irritations which has given rise to natural ingredients or at least products free from parabens and aluminum or alcohol.
Although this provides new entrants with an opportunity to enter this niche market; products with natural ingredients can
be expensive to produce and players such as Dove (owned by Unilever) are already well established in this sector. This
can also act as a barrier to entry.
-
8/18/2019 Global Skin Care
20/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 20
There are also various opportunities for product diversification, for example in premium anti-agers, which are among the
market's strongest growth categories. These can be diversified by the incorporation of extra benefits, such as UV
protection, to help add value and justify higher prices. As skin care becomes increasingly saturated, personalized and
targeted products will become more popular.
The primary drivers of growth within the skincare market include the ageing of developed countries' populations, the
growth of the middle classes in emerging economies, technological developments within the industry, and the increasing
health & wellness awareness. There is in general potential for future growth in the market then, which will work to
encourage new entrants.
Overall, the threat of new entrants to the skincare market is assessed as moderate.
-
8/18/2019 Global Skin Care
21/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 21
Threat of substitutesFigure 13: Factors influencing the threat of substitutes in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
Substitutes for consumer skincare products include traditional or homemade products.
The usage of homemade products may be significant in some undeveloped markets. However, such homemade
alternatives require time and specific knowledge on product composition for their preparation.
Furthermore, such substitutes may not offer the same effects or added benefits of branded cosmetic products and mayonly fulfill basic requirements.
Counterfeited cosmetics constitute a serious substitutive threat for retail outlets and manufacturers, offering the benefit of
much lower price, though at the potential cost of lower quality.
Overall, the threat of substitutes is assessed as weak.
-
8/18/2019 Global Skin Care
22/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 22
Degree of rivalryFigure 14: Drivers of degree of rivalry in the global skincare market, 2014
SOURCE: MARKETLINE M A R K E T L I N E
The global skincare market is relatively fragmented, with the four leading players, L'Oreal, Beiersdorf AG, Unilever and
Johnson & Johnson, accounting for 38.4% of the market.
The main market players are large international companies, who can compete intensely on price, increasing rivalry.
The scale of leading players' operations also drives up rivalry further, as large scale operations in this market incur highoperating and exit costs.
On the other hand, many market players offer a broad product portfolio ranging well beyond the skincare market, often
including household products or food, for example. This diversification alleviates rivalry by reducing players' dependence
on success in this one market.
Strong to moderate growth in recent years has worked to decrease rivalry, and there is scope for growth to continue in
future, both in advanced economies (with their ageing populations) and emerging economies (with their growing middle
classes).
Overall, rivalry is assessed as moderate.
-
8/18/2019 Global Skin Care
23/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 23
LEADING COMPANIES
Beiersdorf AGTable 9: Beiersdorf AG: key facts
Head office: Unnastrasse 48, 20245 Hamburg, DEU
Telephone: 49 40 4909 0
Fax: 49 40 4909 3434
Website: www.beiersdorf.com
Financial year-end: December
Ticker: BEI
Stock exchange: Frankfurt
SOURCE: COMPANY WEBSITE M A R K E T L I N E
Beiersdorf is an international consumer goods company, which is principally engaged in the manufacture of skin and
beauty products. The major brands of the company include Nivea, Eucerin, La Prairie, Labello, Hansaplast, Florena, 8x4,
Hidro Fugal, atrix, Aquaphor, Slek, Maestro and tesa. Beiersdorf operates across the world and has more than 150
affiliates.
The company operates through two business segments: consumer and tesa.
The consumer segment is engaged in the development, manufacturing and marketing of skin and body care products.
The segment offers deodorants, hair care products, men's grooming products, skin care products, personal care
products and professional wound care products. These products are marketed across the world under various brand
names such as 8X4 (deodorants), Nivea (skin care products), Nivea for Men (men's grooming products), Eucerin
(medical skin care), Labello (lip care products), Florena (natural skin care products), Hansaplast (plaster and wound care
products), and La Prairie (anti-aging products).
The tesa segment develops, manufactures and markets self-adhesive products and system solutions for industry, craft
businesses and consumers. The segment manufactures and markets more than 6,500 product and system solutions
globally. In the industrial segment, it caters to customers primarily in the electronics, printing, paper, construction and
automotive industries. For the pharmaceutical industry, tesa develops and produces transdermal systems and oral films.
In addition to office products such as the classic tesafilm adhesive tape, this segment offers solutions for insulation,
painting and masking, repairing, packaging, and mounting. The segment also offers household insect protection
products.
Key Metrics
The company recorded revenues of $8,341 million in the fiscal year ending December 2014, an increase of 2.3%
compared to fiscal 2013. Its net income was $713 million in fiscal 2014, compared to a net income of $721 million in the
preceding year.
-
8/18/2019 Global Skin Care
24/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 24
Table 10: Beiersdorf AG: key financials ($)
$ million 2010 2011 2012 2013 2014
Revenues 7,393.5 7,475.8 8,015.9 8,150.0 8,341.1
Net income (loss) 432.6 343.7 590.6 720.6 712.7
Total assets 6,761.8 7,000.7 7,426.7 7,694.8 8,400.8Total liabilities 2,886.5 2,998.0 3,255.5 3,175.8 3,570.0
Employees 19,128 17,666 16,605 16,708 17,398
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 11: Beiersdorf AG: key financials (€)
€ million 2010 2011 2012 2013 2014
Revenues 5,571.0 5,633.0 6,040.0 6,141.0 6,285.0
Net income (loss) 326.0 259.0 445.0 543.0 537.0
Total assets 5,095.0 5,275.0 5,596.0 5,798.0 6,330.0
Total liabilities 2,175.0 2,259.0 2,453.0 2,393.0 2,690.0
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 12: Beiersdorf AG: key financial ratios
Ratio 2010 2011 2012 2013 2014
Profit margin 5.9% 4.6% 7.4% 8.8% 8.5%
Revenue growth (3.1%) 1.1% 7.2% 1.7% 2.3%
Asset growth 10.9% 3.5% 6.1% 3.6% 9.2%
Liabilities growth 11.1% 3.9% 8.6% (2.4%) 12.4%
Debt/asset ratio 42.7% 42.8% 43.8% 41.3% 42.5%
Return on assets 6.7% 5.0% 8.2% 9.5% 8.9%
Revenue per employee $386,527 $423,173 $482,742 $487,788 $479,427
Profit per employee $22,619 $19,457 $35,566 $43,131 $40,963
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
25/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 25
Figure 15: Beiersdorf AG: revenues & profitability
SOURCE: COMPANY FILINGS M A R K E T L I N E
Figure 16: Beiersdorf AG: assets & liabilities
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
26/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 26
Johnson & JohnsonTable 13: Johnson & Johnson: key facts
Head office:One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933USA
Telephone: 1 732 524 0400
Website: www.jnj.com
Financial year-end: December
Ticker: JNJ
Stock exchange: New York
SOURCE: COMPANY WEBSITE M A R K E T L I N E
Johnson & Johnson (J&J) is a global manufacturer of health care products as well as a provider of related services. The
company conducts its international business through more than 275 operating companies across the globe. It has major
operations in the Americas, Europe, Asia Pacific and Africa.
The company operates through three segments: medical devices and diagnostics, pharmaceuticals, and consumer.
J&J's consumer segment develops, manufactures and markets products for baby care, skin care, oral care, wound care
and women's health care. It also offers nutritional and over-the-counter (OTC) pharmaceutical products. Its major brands
include: Aveeno (skin care products); Band-Aid (adhesive bandages); Carefree (panty liners); Clean & Clear (skin care
products for teens); Johnson's baby and adult lines of products; Motrin IB (ibuprofen products); Neutrogena (skin and
hair care products); RoC (skin care products); Pepcid AC (acid controller); Listerine and Reach (oral care products);
Dabao (moisturizers); Zyrtec (allergy products); Splenda (sweetener); Stayfree (sanitary protection products); and
Tylenol (acetaminophen products). The company sells its products to wholesalers and directly to independent and chain
retail outlets throughout the world.
J&J's medical devices and diagnostics segment manufactures and markets products used by physicians, nurses,
therapists, hospitals, diagnostic laboratories and clinics. These include products to treat cardiovascular diseases;
orthopedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery,
biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact
lenses. The company's products are distributed to wholesalers, hospitals and retailers. In June 2014, J&J completed the
divestiture of its Ortho-Clinical Diagnostics business, a global provider of solutions for screening, diagnosing, monitoring
and confirming diseases, to The Carlyle Group for approximately $4 billion.
-
8/18/2019 Global Skin Care
27/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 27
The pharmaceutical segment produces and markets products in the following therapeutic areas: anti-infective,
antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology,
oncology, pain management, thrombosis and vaccines. Key products in the pharmaceutical segment include: Remicade
(infliximab), for the symptoms of Crohn's disease, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, chronic
severe plaque psoriasis and rheumatoid arthritis; Stelara (ustekinumab), a treatment for adults with moderate to severe
plaque psoriasis; Simponi (golimumab), a treatment for adults with moderate to severe rheumatoid arthritis, activepsoriatic arthritis, and active ankylosing spondylitis; Velcade (bortezomib), a treatment for multiple myeloma; Zytiga
(abiraterone acetate), a treatment for metastatic castration-resistant prostate cancer; Prezista (darunavir), Intellence
(etravirine) and Edurant (rilpivirine), treatments for HIV/AIDS; Incivo (telaprevir), for the treatment of hepatitis C; Nucynta
ER (tapentadol) extended release tablets, a treatment for moderate to severe chronic pain in adults and neuropathic pain
associated with diabetic peripheral neuropathy in adults; Invega Sustenna (paliperidone palmitate), for the acute and
maintenance treatment of schizophrenia in adults; Invega (paliperidone) extended-release tablets, for the treatment of
schizophrenia and schizoaffective disorder; Risperdal Consta (risperidone), a treatment for the management of Bipolar I
Disorder and schizophrenia; Xarelto (rivaroxaban), an oral anticoagulant for the prevention of thrombosis following total
hip or knee replacement surgery, for the prevention of stroke in patients with atrial fibrillation, for the treatment of
pulmonary embolism (PE) or deep vein thrombosis (DVT) or to reduce the risk of recurrence of DVT or PE following an
initial six months of treatment for acute venous thromboembolism; Procrit (epoetin alfa, sold outside the US as Eprex), to
stimulate red blood cell production; Concerta (methylphenidate HCl) extended-release tablets CII, a treatment for
attention deficit hyperactivity disorder; and Aciphex EX /Pariet , a proton pump inhibitor co-marketed with Eisai. J&J's
products are distributed directly to retailers, wholesalers and health care professionals.
Key Metrics
The company recorded revenues of $74,331 million in the fiscal year ending December 2014, an increase of 4.2%
compared to fiscal 2013. Its net income was $16,323 million in fiscal 2014, compared to a net income of $13,831 million
in the preceding year.
Table 14: Johnson & Johnson: key financials ($)
$ million 2010 2011 2012 2013 2014
Revenues 61,587.0 65,030.0 67,200.0 71,312.0 74,331.0
Net income (loss) 13,334.0 9,672.0 10,510.3 13,831.0 16,323.0
Total assets 102,908.0 113,644.0 121,347.0 132,683.0 131,119.0
Total liabilities 46,329.0 56,564.0 56,521.0 58,630.0 61,367.0
Employees 114,000 117,000 127,600 128,100 126,500
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
28/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 28
Table 15: Johnson & Johnson: key financial ratios
Ratio 2010 2011 2012 2013 2014
Profit margin 21.7% 14.9% 15.6% 19.4% 22.0%
Revenue growth (0.5%) 5.6% 3.3% 6.1% 4.2%
Asset growth 8.7% 10.4% 6.8% 9.3% (1.2%)Liabilities growth 5.1% 22.1% (0.1%) 3.7% 4.7%
Debt/asset ratio 45.0% 49.8% 46.6% 44.2% 46.8%
Return on assets 13.5% 8.9% 8.9% 10.9% 12.4%
Revenue per employee $540,237 $555,812 $526,646 $556,690 $587,597
Profit per employee $116,965 $82,667 $82,369 $107,970 $129,036
SOURCE: COMPANY FILINGS M A R K E T L I N E
Figure 17: Johnson & Johnson: revenues & profitability
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
29/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 29
Figure 18: Johnson & Johnson: assets & liabilities
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
30/39
-
8/18/2019 Global Skin Care
31/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 31
Table 17: L'Oreal S.A.: key financials ($)
$ million 2010 2011 2012 2013 2014
Revenues 25,873.7 26,998.1 28,717.2 29,361.9 29,903.1
Net income (loss) 2,972.4 3,236.1 3,805.8 3,925.9 6,516.5
Total assets 31,910.4 35,651.6 38,797.7 40,980.6 42,552.1
Total liabilities 12,181.4 12,258.3 11,026.7 10,930.5 15,758.9
Employees 64,643 66,619 68,886 72,600 77,500
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 18: L'Oreal S.A.: key financials (€)
€ million 2010 2011 2012 2013 2014
Revenues 19,495.8 20,343.1 21,638.4 22,124.2 22,532.0
Net income (loss) 2,239.7 2,438.4 2,867.7 2,958.2 4,910.2
Total assets 24,044.5 26,863.5 29,234.1 30,878.9 32,063.0
Total liab lities 9,178.7 9,236.6 8,308.6 8,236.1 11,874.3
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 19: L'Oreal S.A.: key financial ratios
Ratio 2010 2011 2012 2013 2014
Profit margin 11.5% 12.0% 13.3% 13.4% 21.8%
Revenue growth 11.6% 4.3% 6.4% 2.2% 1.8%
Asset growth 3.2% 11.7% 8.8% 5.6% 3.8%
Liabilities growth (5.3%) 0.6% (10.0%) (0.9%) 44.2%
Debt/asset ratio 38.2% 34.4% 28.4% 26.7% 37.0%
Return on assets 9.5% 9.6% 10.2% 9.8% 15.6%
Revenue per employee $400,255 $405,262 $416,880 $404,434 $385,847
Profit per employee $45,982 $48,576 $55,248 $54,076 $84,084
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
32/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 32
Figure 19: L'Oreal S.A.: revenues & profitability
SOURCE: COMPANY FILINGS M A R K E T L I N E
Figure 20: L'Oreal S.A.: assets & liabilities
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
33/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 33
UnileverTable 20: Unilever: key facts
Head office: Unilever House, 100 Victoria Embankment, London, EC4Y 0DY, GBR
Telephone: 44 20 7822 5252Fax: 44 20 7822 5951
Website: www.unilever.com
Financial year-end: December
Ticker: ULVR
Stock exchange: London
SOURCE: COMPANY WEBSITE M A R K E T L I N E
Unilever is a dual-listed company with two parent companies, Unilever N.V. and Unilever PLC. Unilever N.V. is a publiclimited company registered in the Netherlands, whereas Unilever PLC is a public limited company registered in England
and Wales. These two companies function as a single operating business, but retain separate legal identities and stock
exchange listings. The two parent companies, together with their Group companies, operate as a single entity (Unilever).
Unilever is one of the world's premier FMCG companies with a host of well-known brands in the foods, home and
personal care categories.
The group operates through four product segments: personal care, foods, refreshment, and home care.
The personal care segment includes skin care and hair care products, deodorants and oral care products. The group's
major brands in this segment include Dove, Lux, Rexona, Sunsilk, Axe, Pond's, Lifebuoy, Vaseline, and Close Up.
Simple and Dove are two of the company's best-known skin and facial care brands.
The foods segment includes sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and
spreads, and cooking products such as liquid margarines. Key brands operating under this segment are Knorr, Blue
Band, Rama, Hellmann's and Amora.
Unilever's refreshment segment includes sales of ice cream, tea-based beverages, weight-management products, and
nutritionally enhanced staples sold in developing markets. Wall's, Lipton, SlimFast, Becel and Flora are the key brands
sold under the refreshments segment.
The home care segment includes sales of home care products, such as powders, liquids and capsules, soap bars and a
wide range of cleaning products. Unilever's global brands in this segment include Omo, Surf, Comfort, Cif, Domestos and
Sunlight.
Key Metrics
The company recorded revenues of $64,281 million in the fiscal year ending December 2014, a decrease of 2.7%
compared to fiscal 2013. Its net income was $6,863 million in fiscal 2014, compared to a net income of $6,426 million in
the preceding year.
-
8/18/2019 Global Skin Care
34/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 34
Table 21: Unilever: key financials ($)
$ million 2010 2011 2012 2013 2014
Revenues 58,741.9 61,668.2 68,114.1 66,087.6 64,281.4
Net income (loss) 5,632.4 6,135.4 5,945.6 6,426.0 6,862.6
Total assets 55,032.5 63,055.1 61,268.7 60,402.1 63,738.6Total liabilities 34,623.8 43,252.8 40,411.4 40,740.5 44,809.6
Employees 165,000 169,000 173,000 174,381 172,471
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 22: Unilever: key financials (€)
€ million 2010 2011 2012 2013 2014
Revenues 44,262.0 46,46 .0 51,324.0 49,797.0 48,436.0
Net income (loss) 4,244.0 4,623.0 4,480.0 4,842.0 5,171.0
Total assets 41,467.0 47,512.0 46,166.0 45,513.0 48,027.0
Total liabilities 26,089.0 32,591.0 30,450.0 30,698.0 33,764.0
SOURCE: COMPANY FILINGS M A R K E T L I N E
Table 23: Unilever: key financial ratios
Ratio 2010 2011 2012 2013 2014
Profit margin 9.6% 9.9% 8.7% 9.7% 10.7%
Revenue growth 11.1% 5.0% 10.5% (3.0%) (2.7%)
Asset growth 12.0% 14.6% (2.8%) (1.4%) 5.5%
Liabilities growth 6.6% 24.9% (6.6%) 0.8% 10.0%
Debt/asset ratio 62.9% 68.6% 66.0% 67.4% 70.3%
Return on assets 10.8% 10.4% 9.6% 10.6% 11.1%
Revenue per employee $356,011 $364,901 $393,723 $378,984 $372,708
Profit per employee $34,136 $36,304 $34,368 $36,850 $39,790
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
35/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 35
Figure 21: Unilever: revenues & profitability
SOURCE: COMPANY FILINGS M A R K E T L I N E
Figure 22: Unilever: assets & liabilities
SOURCE: COMPANY FILINGS M A R K E T L I N E
-
8/18/2019 Global Skin Care
36/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 36
METHODOLOGY
MarketLine Industry Profiles draw on extensive primary and secondary research, all aggregated, analyzed, cross-
checked and presented in a consistent and accessible style.
Review of in-house databases – Created using 250,000+ industry interviews and consumer surveys and supported byanalysis from industry experts using highly complex modeling & forecasting tools, MarketLine’s in -house databases
provide the foundation for all related industry profiles
Preparatory research – We also maintain extensive in-house databases of news, analyst commentary, company
profiles and macroeconomic & demographic information, which enable our researchers to build an accurate market
overview
Definitions – Market definitions are standardized to allow comparison from country to country. The parameters of each
definition are carefully reviewed at the start of the research process to ensure they match the requirements of both the
market and our clients
Extensive secondary research activities ensure we are always fully up-to-date with the latest industry events and
trends
MarketLine aggregates and analyzes a number of secondary information sources, including:
- National/Governmental statistics
- International data (official international sources)
- National and International trade associations
- Broker and analyst reports
- Company Annual Reports
- Business information libraries and databases
Modeling & forecasting tools – MarketLine has developed powerful tools that allow quantitative and qualitative data to
be combined with related macroeconomic and demographic drivers to create market models and forecasts, which can
then be refined according to specific competitive, regulatory and demand-related factors
Continuous quality control ensures that our processes and profiles remain focused, accurate and up-to-date
-
8/18/2019 Global Skin Care
37/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 37
Industry associations
The Cosmetic, Toiletry, and Fragrance Association
1101 17th Street, NW, Suite 300, Washington D.C. 20036-4702, USA
Tel.: 1 202 3311 770
Fax: 1 202 3311 969www.ctfa.org
Aesthetics' International Association2611 N. Beltline Rd., Suite 140, Sunnyvale, TX 75182, USA
Tel.: 1 972 203 8530
Fax: 1 972 226 2339
www.aestheticsassociation.com/
Related MarketLine research
Industry ProfileSkincare in Europe
Skincare in Asia-Pacific
Skincare in the United States
Skincare in Germany
Skincare in Japan
-
8/18/2019 Global Skin Care
38/39
Global - Skincare 0199 - 0708 - 2014
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED Page | 38
APPENDIX
About MarketLineIn an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the solution.
We make it our job to sort through the data and deliver accurate, up-to-date information on companies, industries and
countries across the world. No other business information company comes close to matching our sheer breadth of
coverage.
And unlike many of our competitors, we cut the ‘data padding’ and present information in easy -to-digest formats, so you
can absorb key facts in minutes, not hours.
What we do
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific publishers of business
information today.
Our dedicated research professionals aggregate, analyze, and cross-check facts in line with our strict researchmethodology, ensuring a constant stream of new and accurate information is added to MarketLine every day.
With stringent checks and controls to capture and validate the accuracy of our data, you can be confident in MarketLine
to deliver quality data in an instant.
For further information about our products and services see more at: http://www.marketline.com/overview/
Disclaimer
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, MarketLine.
The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that
the findings, conclusions and recommendations that MarketLine delivers will be based on information gathered in good
faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such
MarketLine can accept no liability whatever for actions taken based on any information that may subsequently prove to
be incorrect.
http://www.marketline.com/overview/http://www.marketline.com/overview/http://www.marketline.com/overview/http://www.marketline.com/overview/
-
8/18/2019 Global Skin Care
39/39